Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer.
Eva Ciruelos GilMaría Nieves DíazMaría Dolores IslaRafael LópezReyes BernabéEncarnación GonzálezBeatriz CirauquiJuan CovesSerafín MoralesAlberto ArcedianoIsidoro BarnetoPablo CerezuelaJosé Juan IllarramendiCristina MoralesSantiago PoncePublished in: European journal of cancer care (2019)
Convenience, ease of administration, fewer side effects and better quality of life tilt the balance towards oral drug administration.